INTRAVASKULÄRE BLUTPUMPEN
European patent · EP4085965 · In force
Register entry
- Publication number
- EP4085965
- Application number
- EP22177389
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Feb 1, 2019
- Published
- Nov 9, 2022
- Granted
- Sep 23, 2026
- Protection ends at the latest
- Jan 31, 2039
- Next annual fee due
- Feb 28, 2027
- IPC classes
- A61M 60/13 (2021.01)A61M 60/237 (2021.01)A61M 60/414 (2021.01)A61M 60/806 (2021.01)A61M 60/808 (2021.01)A61M 60/857 (2021.01)A61M 60/865 (2021.01)A61M 60/139 (2021.01)A61M 60/174 (2021.01)A61M 60/804 (2021.01)A61M 60/81 (2021.01)A61M 60/818 (2021.01)
- Priority
- US 201862625312 P 01.02.2018
- Divided from
- EP19746925
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 23, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 23.09.2026
Parties
Inventor
SALAHIEH, Amr
Campbell, 95008, US
SAUL, Tom
Campbell, 95008, US
ESCH, Brady
Campbell, 95008, US
KERLO, Anna
Campbell, 95008, US
HILDEBRAND, Daniel
Campbell, 95008, US
VARGHAI, Daniel
Campbell, 95008, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.